VVOS - MCAP CO - Vivos Therapeutics

The Vivos Therapeutics (VVOS) price chart reflects the market position of a company combating a narrow product profile by expanding insurance coverage, with a market capitalization of 0.00. The business relies on FDA-certified apnea devices, generating a recurring revenue stream from software and components. Revenue is driven by innovative oral appliances, which are sought after by somnologists as a comfortable alternative to bulky masks.

Market capitalization is the product of the current share price and the total number of outstanding securities. This metric measures the aggregate market value of a business, reflecting investor expectations regarding future cash flows. By analyzing the market value of an issuer on the GURU.Markets platform, one can identify speculative deviations from fundamental value. For Vivos Therapeutics (VVOS), this indicator is sensitive to the costs of implementing new medical protocols. High physician training expenses may temporarily depress the company's valuation, despite the possession of regulatory approvals.